Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 5.18
SONVY's Cash to Debt is ranked higher than
75% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.27 vs. SONVY: 5.18 )
SONVY' s 10-Year Cash to Debt Range
Min: 0.44   Max: No Debt
Current: 5.18

Equity to Asset 0.68
SONVY's Equity to Asset is ranked higher than
74% of the 453 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SONVY: 0.68 )
SONVY' s 10-Year Equity to Asset Range
Min: 0.48   Max: 0.72
Current: 0.68

0.48
0.72
F-Score: 5
Z-Score: 9.37
M-Score: -2.51
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 20.76
SONVY's Operating margin (%) is ranked higher than
94% of the 458 Companies
in the Global Medical Devices industry.

( Industry Median: 5.49 vs. SONVY: 20.76 )
SONVY' s 10-Year Operating margin (%) Range
Min: -6.79   Max: 27.12
Current: 20.76

-6.79
27.12
Net-margin (%) 17.55
SONVY's Net-margin (%) is ranked higher than
93% of the 458 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. SONVY: 17.55 )
SONVY' s 10-Year Net-margin (%) Range
Min: -8.51   Max: 23.65
Current: 17.55

-8.51
23.65
ROE (%) 19.88
SONVY's ROE (%) is ranked higher than
94% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.07 vs. SONVY: 19.88 )
SONVY' s 10-Year ROE (%) Range
Min: -14.42   Max: 32.24
Current: 19.88

-14.42
32.24
ROA (%) 13.38
SONVY's ROA (%) is ranked higher than
95% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.61 vs. SONVY: 13.38 )
SONVY' s 10-Year ROA (%) Range
Min: -6.95   Max: 22.05
Current: 13.38

-6.95
22.05
ROC (Joel Greenblatt) (%) 90.44
SONVY's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 8.37 vs. SONVY: 90.44 )
SONVY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -33.7   Max: 119.1
Current: 90.44

-33.7
119.1
Revenue Growth (%) 6.20
SONVY's Revenue Growth (%) is ranked higher than
76% of the 339 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. SONVY: 6.20 )
SONVY' s 10-Year Revenue Growth (%) Range
Min: -88.2   Max: 56.1
Current: 6.2

-88.2
56.1
EBITDA Growth (%) 8.90
SONVY's EBITDA Growth (%) is ranked higher than
83% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. SONVY: 8.90 )
SONVY' s 10-Year EBITDA Growth (%) Range
Min: -85.7   Max: 42.5
Current: 8.9

-85.7
42.5
EPS Growth (%) 13.50
SONVY's EPS Growth (%) is ranked higher than
85% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. SONVY: 13.50 )
SONVY' s 10-Year EPS Growth (%) Range
Min: -84.9   Max: 41.4
Current: 13.5

-84.9
41.4
» SONVY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with SONVY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.70
SONVY's P/E(ttm) is ranked higher than
86% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 106.60 vs. SONVY: 28.70 )
SONVY' s 10-Year P/E(ttm) Range
Min: 0.03   Max: 77.01
Current: 28.7

0.03
77.01
P/B 5.51
SONVY's P/B is ranked higher than
62% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.78 vs. SONVY: 5.51 )
SONVY' s 10-Year P/B Range
Min: 0.01   Max: 10.62
Current: 5.51

0.01
10.62
P/S 5.02
SONVY's P/S is ranked higher than
63% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. SONVY: 5.02 )
SONVY' s 10-Year P/S Range
Min: 2.47   Max: 8.02
Current: 5.02

2.47
8.02
PFCF 30.91
SONVY's PFCF is ranked higher than
87% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SONVY: 30.91 )
SONVY' s 10-Year PFCF Range
Min: 12.7   Max: 82.69
Current: 30.91

12.7
82.69
EV-to-EBIT 23.57
SONVY's EV-to-EBIT is ranked higher than
82% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 73.45 vs. SONVY: 23.57 )
SONVY' s 10-Year EV-to-EBIT Range
Min: -0.3   Max: 53.1
Current: 23.57

-0.3
53.1
Shiller P/E 38.66
SONVY's Shiller P/E is ranked higher than
89% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SONVY: 38.66 )
SONVY' s 10-Year Shiller P/E Range
Min: 0.27   Max: 41.26
Current: 38.66

0.27
41.26
Current Ratio 1.94
SONVY's Current Ratio is ranked higher than
62% of the 474 Companies
in the Global Medical Devices industry.

( Industry Median: 2.72 vs. SONVY: 1.94 )
SONVY' s 10-Year Current Ratio Range
Min: 1.6   Max: 2.56
Current: 1.94

1.6
2.56
Quick Ratio 1.56
SONVY's Quick Ratio is ranked higher than
65% of the 474 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. SONVY: 1.56 )
SONVY' s 10-Year Quick Ratio Range
Min: 1.13   Max: 2.19
Current: 1.56

1.13
2.19

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.82
SONVY's Dividend Yield is ranked lower than
68% of the 185 Companies
in the Global Medical Devices industry.

( Industry Median: 1.37 vs. SONVY: 0.82 )
SONVY' s 10-Year Dividend Yield Range
Min: 0.61   Max: 1.3
Current: 0.82

0.61
1.3
Dividend Payout 0.21
SONVY's Dividend Payout is ranked higher than
93% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SONVY: 0.21 )
SONVY' s 10-Year Dividend Payout Range
Min: 0.21   Max: 0.31
Current: 0.21

0.21
0.31
Dividend growth (3y) 10.10
SONVY's Dividend growth (3y) is ranked higher than
81% of the 104 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. SONVY: 10.10 )
SONVY' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 10.1
Current: 10.1

0
10.1
Yield on cost (5-Year) 0.80
SONVY's Yield on cost (5-Year) is ranked lower than
66% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 1.57 vs. SONVY: 0.80 )
SONVY' s 10-Year Yield on cost (5-Year) Range
Min: 0.61   Max: 1.3
Current: 0.8

0.61
1.3
Share Buyback Rate -0.30
SONVY's Share Buyback Rate is ranked higher than
84% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -1.40 vs. SONVY: -0.30 )
SONVY' s 10-Year Share Buyback Rate Range
Min: 25.5   Max: -906.6
Current: -0.3

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 15.95
SONVY's Price/Tangible Book is ranked higher than
59% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 6.57 vs. SONVY: 15.95 )
SONVY' s 10-Year Price/Tangible Book Range
Min: 0.01   Max: 28.05
Current: 15.95

0.01
28.05
Price/DCF (Projected) 2.37
SONVY's Price/DCF (Projected) is ranked higher than
86% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SONVY: 2.37 )
SONVY' s 10-Year Price/DCF (Projected) Range
Min: 1.51   Max: 8.78
Current: 2.37

1.51
8.78
Price/Median PS Value 1.05
SONVY's Price/Median PS Value is ranked higher than
78% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. SONVY: 1.05 )
SONVY' s 10-Year Price/Median PS Value Range
Min: 0.33   Max: 1.22
Current: 1.05

0.33
1.22
Price/Graham Number 4.46
SONVY's Price/Graham Number is ranked higher than
77% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SONVY: 4.46 )
SONVY' s 10-Year Price/Graham Number Range
Min: 2.29   Max: 7.29
Current: 4.46

2.29
7.29
Earnings Yield (Greenblatt) 4.20
SONVY's Earnings Yield (Greenblatt) is ranked higher than
81% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SONVY: 4.20 )
SONVY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.9   Max: 11.5
Current: 4.2

1.9
11.5
Forward Rate of Return (Yacktman) -0.91
SONVY's Forward Rate of Return (Yacktman) is ranked higher than
71% of the 349 Companies
in the Global Medical Devices industry.

( Industry Median: 0.59 vs. SONVY: -0.91 )
SONVY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -63.6   Max: 33.8
Current: -0.91

-63.6
33.8

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:SOON.Switzerland, PHBN.Germany, 0QPY.UK
Sonova Holding AG was formed on August 1, 2007, from Phonak Holding AG. The Company is the hearing care provider in the industry. It provides comprehensive hearing solutions. Its brands Phonak, Unitron, Advanced Bionics and Connect Hearing create compelling new products and offer the optimal solution for every user. The Company operates in two segments: Hearing instruments which includes the companies that are active in the design, development, manufacture, distribution and service of hearing instruments and related products. Research and development is centralized in Switzerland while some activities are also performed in Canada. Production of hearing instruments is concentrated in three production centers in Switzerland, China, and Vietnam; and Cochlear implants which includes the companies that are active in the design, development, manufacture, distribution and service of hearing implants and related products. The segment consists of Advanced Bionics and the related sales organizations, which were acquired as of December 30, 2009 and which provide cochlear implant systems.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK